Bora Pharmaceuticals Co., LTD. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 10,494.47 million compared to TWD 4,899.89 million a year ago. Net income was TWD 1,391.92 million compared to TWD 749.74 million a year ago.

Basic earnings per share from continuing operations was TWD 14.2582 compared to TWD 7.7296 a year ago. Diluted earnings per share from continuing operations was TWD 14.0888 compared to TWD 7.7065 a year ago.